Clinical Validation of Whole Genome Sequencing for Cancer Diagnostics
Open Access
- 1 July 2021
- journal article
- research article
- Published by Elsevier in The Journal of Molecular Diagnostics
- Vol. 23 (7) , 816-833
Abstract
No abstract availableKeywords
All Related Versions
This publication has 39 references indexed in Scilit:
- DNA damage is a pervasive cause of sequencing errors, directly confounding variant identificationScience, 2017
- Implementing Genome-Driven OncologyCell, 2017
- Reliable Next-Generation Sequencing of Formalin-Fixed, Paraffin-Embedded Tissue Using Single Molecule TagsThe Journal of Molecular Diagnostics, 2016
- Integration of next-generation sequencing in clinical diagnostic molecular pathology laboratories for analysis of solid tumours; an expert opinion on behalf of IQN Path ASBLVirchows Archiv, 2016
- MSIseq: Software for Assessing Microsatellite Instability from Catalogs of Somatic MutationsScientific Reports, 2015
- Personalized genomic analyses for cancer mutation discovery and interpretationScience Translational Medicine, 2015
- Sequence Artifacts in DNA from Formalin-Fixed Tissues: Causes and Strategies for MinimizationClinical Chemistry, 2015
- The Cancer Genome Atlas Pan-Cancer analysis projectNature Genetics, 2013
- A Five-marker Panel in a Multiplex PCR Accurately Detects Microsatellite Instability-high Colorectal Tumors Without Control DNADiagnostic Molecular Pathology, 2012
- A review on the molecular diagnostics of Lynch syndrome: a central role for the pathology laboratoryJournal of Cellular and Molecular Medicine, 2010